- Chikungunya vaccine developed by Butantan is safe and generates sustained immune response in 96% of volunteers, study findsGZH
- Chikungunya vaccine is 96% effective, says ButantanLive well
- Rio Preto study attests to the effectiveness of the chikungunya vaccine in the United StatesNewspaper of the region
- Chikungunya vaccine generates immune response in 96% of volunteers, Butantan saysMetro1
- Butantan Releases Chikungunya Vaccine Test ResultsBrazil Television
- See full coverage on Google News
Chikungunya vaccine developed by Butantan is safe and generates sustained immune response in 96% of volunteers, study finds – GZH
10 months ago
No Comments
Related Posts
Learn about the three foot signs that may indicate you have diabetes
April 10, 2022
Are you going to include your pet on vacation? These tips can help everything run smoothly – Marketeer
July 22, 2022
Expert says women are more likely to have mental health issues
March 20, 2022
Health registers 18 additional cases and nine deaths from H3N2 in Paraná – Paiquerê FM News
March 11, 2022
Argentina: Deaths From Bacteria That Cause Pneumonia Rise | AFP – AFP Portuguese
September 7, 2022
Study indicates that deer infected with the Covid virus can harbor the virus and infect humans
March 8, 2022
Centro POP and CERPAT carry out tests on the homeless population in Itabuna.
July 16, 2022
/i461167.jpeg)
Scientists discover a type of Ebola that infects bats and can reach humans
March 3, 2022
Hope for those who had Zica during pregnancy
December 13, 2022
Does lemon seasoning red meat reduce fat?
March 5, 2022
Cabo Frio promotes actions for the prevention and early diagnosis of HIV through the “Red December”
December 7, 2022
Dengue fever: first death is recorded in Piauí – Portal do Trono
March 13, 2022
About The Author
